|
Welcome to datamethods
|
2
|
July 12, 2018
|
|
Language for communicating frequentist results about treatment effects
|
122
|
November 13, 2018
|
|
Methodology - Mediation, Moderation, Regression, MANOVA?
|
2
|
April 17, 2019
|
|
Quality of life surveys and proportional odds models
|
13
|
April 12, 2019
|
|
On surrogate end points in cancer research
|
13
|
April 7, 2019
|
|
Modelling outcome data with a limit of detection. Is a hurdle model appropriate?
|
17
|
March 3, 2019
|
|
Non linear effect
|
9
|
April 9, 2019
|
|
What about this weird 2 arm design (Lancet article)
|
9
|
March 29, 2019
|
|
Statistics Reform
|
46
|
March 11, 2019
|
|
Nonparametric Effect Size estimation, Likelihood Methods, and Meta Analysis
|
7
|
March 27, 2019
|
|
Cluster RCT on PlGF test to diagnose pre-eclampsia - Lancet Publication to immediate national recommendation
|
4
|
April 2, 2019
|
|
Reduction of highly correlated variables in radiation oncology
|
3
|
April 4, 2019
|
|
How To Do Predictive Statistics: New (Free) Software
|
1
|
July 23, 2018
|
|
Responder Analysis: Loser x 4
|
16
|
January 19, 2019
|
|
Monte Carlo simulation for sensitivity and specificity determination
|
2
|
March 24, 2019
|
|
When is censoring too high?
|
4
|
April 1, 2019
|
|
T1 T2 - cross-cultural validation of questionaire
|
1
|
April 2, 2019
|
|
Sample size in mixed model study (exploratory prognostic factor study)
|
9
|
March 28, 2019
|
|
CREOLE Trial: Interpretation of results doesn't line up with statistical plan?
|
8
|
March 28, 2019
|
|
Most reasonably hypothesised effects cannot be exactly zero?
|
14
|
November 28, 2018
|
|
Robust Estimation of Marginal Effects (and Uncertainty) using Bayesian Additive Regression Trees
|
3
|
March 11, 2019
|
|
Cluster-Randomized Trial: Design Question
|
6
|
February 4, 2019
|
|
Treatment effect heterogeneity: or is it?
|
13
|
March 24, 2019
|
|
Errors in teaching critical appraisal of null results (p>0.05) to clinicians
|
6
|
September 27, 2018
|
|
GRADE guidelines and effect estimate & CIs
|
18
|
January 25, 2019
|
|
Discussion of Assessing Heterogeneity of Treatment Effect, Estimating Patient-Specific Efficacy, and Studying Variation in Odds ratios, Risk Ratios, and Risk Differences
|
7
|
March 25, 2019
|
|
Is it reasonable to adjust for baseline covariates that will change with treatment?
|
2
|
March 25, 2019
|
|
Sample size in Epidemiological studies
|
6
|
March 22, 2019
|
|
The Future of Scientific Publishing
|
58
|
March 1, 2019
|
|
Propensity matching and analysis of resultant data on a data set with nonuniform repeated measures
|
6
|
March 15, 2019
|
